Improving risk stratification in patients with prostate cancer managed by active surveillance: a nomogram predicting the risk of biopsy progression.
about
Developing a follow-up strategy for patients with PSA ranging from 4 to 10 ng/ml via a new model to reduce unnecessary prostate biopsiesReclassification rates are higher among African American men than Caucasians on active surveillanceActive surveillance for prostate cancer: a systematic review of clinicopathologic variables and biomarkers for risk stratification.Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary-Early Detection Research Network Active Surveillance Biopsy Risk CalculatorNovel concepts for risk stratification in prostate cancer.Implementation of PSA-based active surveillance in prostate cancer.Prediagnostic prostate-specific antigen kinetics and the risk of biopsy progression in active surveillance patients.Improving risk stratification in patients with prostate cancer managed by active surveillance: nomogram predicting the risk of biopsy progression.Risk prediction tool for grade re-classification in men with favourable-risk prostate cancer on active surveillance.
P2860
Q34276126-37A7FC56-627C-4178-B702-AC51D5122C7DQ34765233-2C133122-D1BF-48BC-9BB8-F82F9031AF79Q35471903-6FA09A12-52D4-4029-92B0-F7C91D1FCE1DQ36093723-B2B89610-83DC-48FF-9406-1F3D6367B9B4Q37708177-52CCC894-DD0F-4595-9041-878E9CB047E7Q38239830-7977A8B1-12B1-4958-B716-EB81945B38E7Q38921318-D6AD3379-575A-4B40-AEBE-45D8DB640D14Q45965686-1BEE7A01-48DA-430A-BE4A-9DE2D454F204Q51609372-F823672B-35D1-4E55-9CAA-3AFCF51C8239
P2860
Improving risk stratification in patients with prostate cancer managed by active surveillance: a nomogram predicting the risk of biopsy progression.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Improving risk stratification ...... he risk of biopsy progression.
@en
Improving risk stratification ...... he risk of biopsy progression.
@nl
type
label
Improving risk stratification ...... he risk of biopsy progression.
@en
Improving risk stratification ...... he risk of biopsy progression.
@nl
prefLabel
Improving risk stratification ...... he risk of biopsy progression.
@en
Improving risk stratification ...... he risk of biopsy progression.
@nl
P2093
P2860
P356
P1433
P1476
Improving risk stratification ...... he risk of biopsy progression.
@en
P2093
Joshua Burdick-Will
Mark S Soloway
Viacheslav Iremashvili
P2860
P356
10.1111/BJU.12112
P577
2013-04-02T00:00:00Z